🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Aakash Desai

University of Alabama at Birmingham

ORCID: 0000-0002-2943-3817
MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.271Author DataRank

Indexed papers

4in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618
Top 58%
0.271DataRank
Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Papers

Driven by 19 papers — median percentile 0. Top paper: “Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study”.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

The Lancet(2020)10.1016/s0140-6736(20)31187-9
N/A
11.9DataRank · unranked
1804 citations

Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera +95 more

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Annals of Oncology(2021)10.1016/j.annonc.2021.02.024
N/A
6.8DataRank · unranked
328 citations

Ali Raza Khaki, Trisha M. Wise‐Draper, Benjamin French, Conor Hennessy, Chih–Yuan Hsu +95 more

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

JAMA Oncology(2022)10.1001/jamaoncol.2022.5357
N/A
1.5DataRank · unranked
63 citations

Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati, Chih–Yuan Hsu +95 more

Cancer Therapy Approval Timings, Review Speed, and Publication of Pivotal Registration Trials in the US and Europe, 2010-2019

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.16183
N/A
0.661DataRank · unranked
81 citations

Aakash Desai, Bishal Gyawali, Philip Savage, Jonathan Krell, Jeremy L. Warner +2 more

Challenges in the implementation of ultrasensitive liquid biopsy approaches in precision oncology

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-006793
N/A
0.592DataRank · unranked
14 citations

Christine M. Lovly, Aakash Desai

Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study

eLife(2023)10.7554/elife.82618
Top 58%
0.271DataRank
Top 58%3 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Timing of US Food and Drug Administration (FDA) cancer drug approvals relative to publication of clinical trial results.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2071
N/A
0.165DataRank · unranked
2 citations

Aakash Desai, Martin W. Schoen, Bishal Gyawali, Eddy J. Chen, Peter Yang +2 more

Outcomes and applicability of a deep learning virtual tumor board (DLVTB) in community-dwelling colorectal cancer (CRC) patients.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e18635
N/A
0DataRank · unranked
1 citations

Arturo Loaiza‐Bonilla, Cagatay Culcuoglu, Kristin Johnston, Selin Kurnaz, Aakash Desai

Advances in cancer research dissemination through the pandemic and beyond

Annals of Oncology(2021)10.1016/j.annonc.2021.02.013
N/A
0DataRank · unranked
0 citations

Ishwaria M. Subbiah, Vivek Subbiah, Aakash Desai

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance

Cancer Cell(2020)10.1016/j.ccell.2020.10.022
N/A
0DataRank · unranked
33 citations

David M. Aboulafia, Melissa Accordino, Jared D. Acoba, Manmeet S. Ahluwalia, Syed A. Ahmad +95 more

Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600–Mutant Tumors

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0950
N/A
0DataRank · unranked
39 citations

Arjun K. Menta, Neha K. Reddy, Aakash Desai, Jason Roszik, Vivek Subbiah +1 more

Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium

The Lancet Healthy Longevity(2022)10.1016/s2666-7568(22)00009-5
N/A
0DataRank · unranked
22 citations

Cassandra Hennessy, Nicole M. Kuderer, Samuel M. Rubinstein, Elizabeth Wulff‐Burchfield, Rachel Rosovsky +45 more

Rationalizing rules for immunotherapy combination trials: About time for precision immunotherapy

Cancer(2022)10.1002/cncr.34514
N/A
0DataRank · unranked
9 citations

Vivek Subbiah, Aakash Desai

Direct-to-Patient Clinical Trials: One Small Step or a Giant Leap?

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0746
N/A
0DataRank · unranked
3 citations

Vivek Subbiah, Aakash Desai

Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

The Medicine Forum(2023)10.1101/2023.03.09.23287038
Top 100%
0DataRank
Top 100%0 citations

Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M. Kuderer, David M. Aboulafia +92 more

Data from Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600–Mutant Tumors

(2023)10.1158/1535-7163.c.6543276.v1
Top 100%
0DataRank
Top 100%0 citations

Arjun K. Menta, Neha K. Reddy, Aakash Desai, Jason Roszik, Vivek Subbiah +1 more

Data from Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600–Mutant Tumors

(2023)10.1158/1535-7163.c.6543276
Top 100%
0DataRank
Top 100%0 citations

Arjun K. Menta, Neha K. Reddy, Aakash Desai, Jason Roszik, Vivek Subbiah +1 more

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Nature Reviews Clinical Oncology(2021)10.1038/s41571-021-00487-z
N/A
0DataRank · unranked
140 citations

Justin F. Gainor, Aparna Hegde, Alison M. Schram, Giuseppe Curigliano, Sumanta K. Pal +19 more

Hallmarks of RET and Co-occuring Genomic Alterations inRET-aberrant Cancers

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0329
N/A
0DataRank · unranked
44 citations

Aakash Desai, Alexander Andreev-Drakhlin, Jason Roszik, Gilbert J. Cote, Vivek Subbiah +1 more